Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | IONS | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Ionis Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 160.01 | 551.98 | 75.00 | ||
| High | 161.33 | 555.23 | 75.66 | ||
| Low | 156.31 | 532.59 | 73.50 | ||
| Latest | 158.29 | 536.59 | 74.12 | ||
| Change | -0.71 | -14.88 | -0.19 | ||
| % Change | -0.45% | -2.70% | -0.26% | ||
| Volume | 2,718,200 | 2,001,900 | 2,984,300 | ||
| 20-Day Average Volume | 1,188,665 | 555,520 | 1,745,925 | ||
| Previous Close | 159.00 | 551.47 | 74.31 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 159.78 | 552.66 | 74.68 | ||
| 20-Day Raw Stochastic | 33.76% | 8.37% | 34.54% | ||
| 20-Day Relative Strength | 55.43 | 41.96 | 48.38 | ||
| Weighted Alpha | +26.93 | +57.34 | +46.71 | ||
| Today's Opinion | 72% Buy | 24% Buy | 80% Sell | ||
| Previous Opinion | 72% Buy | 40% Buy | 72% Sell | ||
| Last Month's Opinion | 56% Buy | 80% Buy | 16% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.72% since 06/11/26 | -1.62% since 06/11/26 | +0.41% since 06/11/26 | ||
| Low | 155.30 on 06/16/26 | 532.59 on 06/18/26 | 72.30 on 06/16/26 | ||
| High | 162.97 on 06/12/26 | 555.92 on 06/17/26 | 75.66 on 06/18/26 | ||
| 1-Month | |||||
| %Chg | +0.69% since 05/18/26 | -5.36% since 05/18/26 | +2.21% since 05/18/26 | ||
| Low | 152.54 on 05/21/26 | 532.59 on 06/18/26 | 72.00 on 05/19/26 | ||
| High | 169.57 on 06/04/26 | 580.39 on 05/27/26 | 78.10 on 05/29/26 | ||
| 3-Month | |||||
| %Chg | +21.10% since 03/18/26 | +1.18% since 03/18/26 | +3.42% since 03/18/26 | ||
| Low | 125.11 on 03/24/26 | 517.59 on 03/24/26 | 68.90 on 03/24/26 | ||
| High | 169.57 on 06/04/26 | 609.35 on 05/06/26 | 79.19 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | +11.60% since 12/18/25 | +5.84% since 12/18/25 | -4.52% since 12/18/25 | ||
| Low | 122.14 on 02/12/26 | 455.63 on 01/20/26 | 68.90 on 03/24/26 | ||
| High | 169.57 on 06/04/26 | 609.35 on 05/06/26 | 86.74 on 02/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,916,059 | 22,776,632 | 12,249,294 | ||
| Shares Outstanding, K | 100,550 | 42,447 | 165,263 | ||
| Annual Sales | 2,860,500,000 | 3,182,700,000 | 943,710,000 | ||
| Annual Net Income | 478,600,000 | 1,334,700,000 | -381,390,000 | ||
| Last Quarter Sales | 814,500,000 | 781,500,000 | 246,090,000 | ||
| Last Quarter Net Income | 197,900,000 | 274,900,000 | -92,530,000 | ||
| 60-Month Beta | 0.40 | 0.57 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.94 on 05/05/26 | 5.82 on 05/06/26 | -0.30 on 04/29/26 | ||
| Earnings Date | 07/29/26 | 07/29/26 | 07/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 26.77 | 20.36 | 0.00 | ||